| |
|
|
| Name: |
VR Adviser LLC |
| City: |
New York |
| State: |
NY |
| Zip: |
10018 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
41 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
RYZB |
Rayzebio, Inc. |
1 |
- |
$62.49 |
$250,574,000 |
4,030,471 |
17.19% |
161,400,000 |
13,624 |
6.63 |
N/A |
|
|
APGE |
Apogee Therapeutics, Inc. |
2 |
- |
$47.13 |
$237,303,000 |
8,493,321 |
16.28% |
56,395,000 |
0 |
22.838 |
N/A |
|
|
PHVS |
Pharvaris N V Ord Shs |
3 |
- |
$0.00 |
$95,247,000 |
3,395,606 |
6.53% |
62,616,000 |
1,832,093 |
10.249 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
4 |
- |
$12.88 |
$84,564,000 |
3,882,623 |
5.8% |
37,277,000 |
800,001 |
8.565 |
N/A |
|
|
FDMT |
4d Molecular Therapeutics Inc. |
5 |
- |
$0.00 |
$69,371,000 |
3,424,031 |
4.76% |
31,181,000 |
424,031 |
10.571 |
N/A |
|
|
MRUS |
Merus Nv |
6 |
- |
$45.04 |
$59,076,000 |
2,148,214 |
4.05% |
18,372,000 |
422,000 |
5.034 |
N/A |
|
|
CABA |
Cabaletta Bio, Inc. |
7 |
- |
$0.00 |
$58,202,000 |
2,563,952 |
3.99% |
28,169,000 |
590,699 |
9.911 |
N/A |
|
|
AGLE |
Aeglea Biotherapeutics, Inc. |
8 |
- |
$0.60 |
$51,061,000 |
2,372,714 |
3.5% |
47,447,000 |
2,077,680 |
3.879 |
N/A |
|
|
KALV |
Kalvista Pharmaceuticals Inc |
9 |
- |
$10.78 |
$50,136,000 |
4,092,731 |
3.44% |
22,048,000 |
1,176,064 |
12.123 |
N/A |
|
|
ELVN |
Enliven Therapeutics Ord Shs |
10 |
- |
$0.00 |
$40,896,000 |
2,954,902 |
2.8% |
532,000 |
0 |
8.352 |
N/A |
|
|
OCUL |
Ocular Therapeutix, Inc |
11 |
New |
$0.00 |
$34,680,000 |
7,775,760 |
2.38% |
34,680,000 |
7,775,760 |
10.892 |
N/A |
|
|
HLVX |
Hillevax, Inc. |
12 |
- |
$12.79 |
$33,304,000 |
2,075,000 |
2.28% |
5,902,000 |
37,687 |
6.207 |
N/A |
|
|
AMAM |
Ambrx Biopharma Adr Represe... |
13 |
- |
$0.00 |
$29,477,000 |
2,070,000 |
2.02% |
5,672,000 |
0 |
2.3 |
N/A |
|
|
TERN |
Terns Pharmaceuticals, Inc. |
14 |
- |
$4.91 |
$29,186,000 |
4,497,117 |
2% |
13,632,000 |
1,404,844 |
8.061 |
N/A |
|
|
DYN |
Dyne Therapeutics, Inc. |
15 |
- |
$24.73 |
$28,913,000 |
2,173,913 |
1.98% |
9,435,000 |
0 |
3.813 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
16 |
- |
$6.02 |
$27,543,000 |
4,684,167 |
1.89% |
-18,128,000 |
0 |
5.923 |
N/A |
|
|
CELC |
Celcuity Inc. |
17 |
- |
$15.92 |
$27,472,000 |
1,885,538 |
1.88% |
8,229,000 |
-219,848 |
8.701 |
N/A |
|
|
MRSN |
Mersana Therapeutics, Inc. |
18 |
- |
$2.94 |
$26,281,000 |
11,328,000 |
1.8% |
11,894,000 |
0 |
10.107 |
N/A |
|
|
ARVN |
Arvinas Holding Company, Llc |
19 |
New |
$32.37 |
$25,840,000 |
627,788 |
1.77% |
25,840,000 |
627,788 |
1.18 |
N/A |
|
|
ATXS |
Astria Therapeutics, Inc |
20 |
New |
$9.00 |
$24,774,000 |
3,225,806 |
1.7% |
24,774,000 |
3,225,806 |
13.004 |
N/A |
|
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
21 |
- |
$38.28 |
$22,800,000 |
495,983 |
1.56% |
-2,188,000 |
-594,017 |
0.808 |
N/A |
|
|
ORIC |
Oric Pharmaceuticals, Inc. |
22 |
- |
$0.00 |
$22,341,000 |
2,428,385 |
1.53% |
9,377,000 |
285,529 |
6.176 |
N/A |
|
|
APLT |
Applied Therapeutics Inc. |
23 |
- |
$0.00 |
$20,938,000 |
6,250,000 |
1.44% |
6,849,000 |
591,966 |
13.018 |
N/A |
|
|
TSHA |
Taysha Gene Therapies, Inc. |
24 |
- |
$0.00 |
$18,431,000 |
10,412,872 |
1.26% |
-27,213,000 |
-4,031,572 |
28.151 |
N/A |
|
|
SVRA |
Savara Inc |
25 |
- |
$4.41 |
$16,450,000 |
3,500,000 |
1.13% |
-10,709,000 |
-3,684,865 |
3.074 |
Biotechnology |
|
|
LYRA |
Lyra Therapeutics, Inc. |
26 |
- |
$0.00 |
$13,496,000 |
2,575,593 |
0.93% |
9,882,000 |
1,651,423 |
4.9 |
N/A |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
27 |
- |
$0.70 |
$9,648,000 |
927,706 |
0.66% |
-3,034,000 |
0 |
6.26 |
N/A |
|
|
PRAX |
Praxis Precision Medicines,... |
28 |
- |
$0.00 |
$7,879,000 |
353,626 |
0.54% |
-1,192,000 |
-4,950,784 |
0.675 |
N/A |
|
|
GHRS |
Gh Research Ord Shs |
29 |
- |
$0.00 |
$7,646,000 |
1,318,327 |
0.52% |
-19,932,000 |
-1,425,798 |
2.699 |
N/A |
|
|
SLRN |
Acelyrin, Inc. |
30 |
- |
$4.24 |
$6,991,000 |
937,113 |
0.48% |
-1,799,000 |
72,781 |
0.964 |
N/A |
|
|
EYPT |
EyePoint Pharmaceuticals Inc |
31 |
New |
$0.44 |
$5,778,000 |
250,000 |
0.4% |
5,778,000 |
250,000 |
0.174 |
Biotechnology |
|
|
TRVI |
Trevi Therapeutics, Inc. |
32 |
- |
$0.00 |
$4,586,000 |
3,422,397 |
0.31% |
-2,875,000 |
0 |
5.712 |
N/A |
|
|
ADVM |
Adverum Biotechnologies, Inc |
33 |
- |
$14.95 |
$3,875,000 |
5,147,547 |
0.27% |
-5,985,000 |
-1,425,753 |
1.183 |
N/A |
|
|
MIST |
Milestone Pharmaceuticals Inc. |
34 |
- |
$0.00 |
$1,545,000 |
925,048 |
0.11% |
-5,302,000 |
-1,283,764 |
3.777 |
N/A |
|
|
OLMA |
Olema Pharmaceuticals, Inc. |
35 |
- |
$0.00 |
$1,081,000 |
77,042 |
0.07% |
130,000 |
0 |
0.192 |
N/A |
|
|
TVTX |
Travere Therapeutics, Inc |
41 |
Closed |
$5.26 |
$0 |
0 |
0% |
-23,456,000 |
-2,623,677 |
0 |
N/A |
|
|
PLRX |
Pliant Therapeutics, Inc. |
40 |
Closed |
$0.00 |
$0 |
0 |
0% |
-5,010,000 |
-288,949 |
0 |
N/A |
|
|
AFMD |
Affimed Nv |
39 |
Closed |
$0.61 |
$0 |
0 |
0% |
-683,000 |
-142,857 |
0 |
N/A |
|
|
RLYB |
Rallybio Corp |
38 |
Closed |
$0.00 |
$0 |
0 |
0% |
-905,000 |
-268,532 |
0 |
N/A |
|
|
SGMT |
Sagimet Biosciences Inc. |
37 |
Closed |
$4.06 |
$0 |
0 |
0% |
-4,532,000 |
-515,000 |
0 |
N/A |
|
|
ACRS |
Aclaris Therapeutics, Inc. |
36 |
Closed |
$1.20 |
$0 |
0 |
0% |
-7,129,000 |
-1,040,754 |
0 |
N/A |
|
